Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-013804

CEO bought 20,000 shares at $5.08 ($101,600)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-04-10 Purchase : show line 1 in the form +20,000 $5.08 $101,600 792,680 D
Open-market purchases · 20,000 sh · avg $5.08 · $101,600
Loading xslF345X05/form4.xml…